Adenosine inhibition of neutrophil damage during reperfusion does not involve K(ATP)-channel activation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 4 42-4, 1997, Pages

  Zhao, Zhi Qing ^a   Todd, James C ^a   Sato, Hiroki ^a   Ma, Xin Liang ^b   Vinten Johansen, J ^a,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine 5' triphosphate sensitive potassium channel; Infarct size; Neutrophil; Reperfusion injury

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

EID: 0030662547     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.4.h1677     Document Type: Article

References (16)

1. 2 receptor mediated coronary vasodilatation in the dog. Cardiovasc. Res. 28: 906-911, 1994.
2. Amsterdam, E. A., G. L. Stahl, H. L. Pan, S. V. Rendig, M. P. Fletcher, and J. C. Longhurst. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H448-H457, 1995.
3. Auchampach, J. A., and G. J. Gross. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J. Cardiovasc. Pharmacol. 23: 554-561, 1994.
4. Belloni, F. L., and T. H. Hintze Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilation. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H720-H727, 1991.
5. Chambers, D. J., M. V. Braimbridge, and D. J. Hearse. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann. Thorac. Surg. 44: 291-297, 1987.
6. Coetzee, W. A. ATP-sensitive potassium channels and myocardial ischemia: why do they open? Cardiovasc. Drugs Ther. 6: 201-208, 1992.
7. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Bes. 69: 571-581, 1991.
8. Cronstein, B. N., R. I. Levin, J. Belanoff, G. Weissmann, and R. Hirschhorn. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78: 760-770, 1986.
9. 2 receptors. J. Immunol. 148: 2201-2206, 1992.
10. Curtis, W. E., A. M. Gillinov, I. C. Wilson, J. M. Bator, R. M. Burch, D. E. Cameron, and T. J. Gardner. Inhibition of neutrophil adhesion reduces myocardial infarct size. Ann. Thorac. Surg. 56: 1069-1072, 1993.
11. Engler, R. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia. Federation Proc. 46: 2407-2412, 1987.
12. Engler, R. L., G. W. Schmid-Schönbein, and R. S. Pavelec. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am. J. Pathol. 111: 98-111, 1983.
13. 2 receptor-mediated vasodepression does not involve a pertussis toxinsensitive G protein. Eur. J. Pharmacol. 236: 255-262, 1993.
14. Galie, N., C. Guarnieri, P. Ussia, M. Zimarino, A. M. Traini, R. Parlangeli, I. Vaona, A. Branzi, and B. Magnani. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J. Cardiovasc. Pharmacol. 26: 477-484, 1996.
15. Gatell, J. A., H. B. Barner, and K. Shevde. Adenosine and myocardial protection. J. Cardiothorac. Vasc. Anesth. 7: 466-480, 1993.
16. Goldfine, I. D., and A. I. Arieff. Rapid inhibition of basal and glucose-stimulated insulin release by xylazine. Endocrinology 105: 920-922, 1979.